0000899243-20-035011.txt : 20201223
0000899243-20-035011.hdr.sgml : 20201223
20201223173545
ACCESSION NUMBER: 0000899243-20-035011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201221
FILED AS OF DATE: 20201223
DATE AS OF CHANGE: 20201223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHELLER RICHARD H
CENTRAL INDEX KEY: 0001214133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 201413734
MAIL ADDRESS:
STREET 1: C/O GENENTECH INC
STREET 2: 1 DNA WAY MS 49
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080-4990
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-21
0
0001743881
BridgeBio Pharma, Inc.
BBIO
0001214133
SCHELLER RICHARD H
C/O BRIDGEBIO PHARMA, INC.
421 KIPLING STREET
PALO ALTO
CA
94301
1
1
0
0
See Remarks
Common Stock
2020-12-21
4
S
0
14928
64.8069
D
91333
D
Common Stock
2020-12-21
4
S
0
45473
65.4828
D
45860
D
Represents the weighted average sale price of the shares sold from $64.15 to $65.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 1 and 2.
Represents the weighted average sale price of the shares sold from $65.15 to $65.76 per share.
Chairman of Research and Development
/s/ Tara Condon, Attorney-in-Fact
2020-12-22